Is Johnson & Johnson A Better Bet Compared To Bristol-Myers Squibb After 15% Decline?Forbes • 03/31/20
Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now24/7 Wall Street • 03/31/20
Are You Looking for a High-Growth Dividend Stock? Bristol-Myers Squibb (BMY) Could Be a Great ChoiceZacks Investment Research • 03/30/20
What’s Behind 300% Jump In Bristol-Myers Squibb’s Cardiovascular Drugs Sales In The Last 4 Years?Forbes • 03/27/20
How Bristol Myers' New MS Drug Has A Leg-Up On A Rival From NovartisInvestors Business Daily • 03/26/20
Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA ApprovalThe Motley Fool • 03/26/20
3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?The Motley Fool • 03/26/20
Bristol-Myers Squibb's new MS drug is approved, launch delayed due to COVID-19Market Watch • 03/26/20
Will The FDA Approve Bristol's MS Drug? Here Are Some Bullish IndicatorsInvestors Business Daily • 03/25/20